Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital

Last updated: December 12, 2024
Sponsor: University Hospital, Basel, Switzerland
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

data collection for treatment data

data collection for microbiological data

data collection for clinical data

Clinical Study ID

NCT04098133
2019-01548; me19Tschudinsutter
  • Ages > 18
  • All Genders

Study Summary

This retrospective and prospective study is to investigate the incidence of Carbapenemase-producing bacteria (CPB) at the University Hospital Basel, the time to detection of CPB and to initiation of infection control measures, the risk factors associated with carriage of CPB, type and duration of previously administrated antibiotic medication, antibiotic treatment, as well as to assess the outcomes of the affected patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with detection of carbapenemase-producing bacteria from January 1st , 2008until December 31st , 2028

Exclusion

Exclusion Criteria:

  • Patients with documented refusal of subsequent use of their data

Study Design

Total Participants: 100
Treatment Group(s): 4
Primary Treatment: data collection for treatment data
Phase:
Study Start date:
August 22, 2019
Estimated Completion Date:
June 30, 2029

Connect with a study center

  • Division of Infectious Diseases and Hospital Epidemiology

    Basel, 4031
    Switzerland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.